Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Amoxapine may be effective for treating ejaculatory dysfunction.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Sodium benzoate at higher doses can harm kidney and liver functions and cause oxidative stress and DNA damage.

Antiandrogens block male hormones and are not safe during pregnancy.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Topical cetirizine may help increase hair count in androgenetic alopecia.

Baricitinib is effective and safe for treating severe alopecia areata.

Finasteride reduced seizures and prevented cognitive issues in rats after neonatal asphyxia but increased anxiety later.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Altering SSAT affects fat metabolism and body fat in mice.

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.